Filed: 8/14/2024ACC: 0001012975-24-000328
📋 What this filing means
EUCLIDEAN CAPITAL LLC filed this quarterly 13F‑HR report disclosing 11 equity positions with a total reported market value of $795.85M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
11
Positions
$795.85M
Total AUM (reported)
22.25M
Total Shares
Allocation by class
TR UNIT$624.21M78.4%
MSCI INDIA ETF$135.27M17.0%
COM$31.39M3.9%
CLASS A COM$4.01M0.5%
COM NEW$960.3K0.1%
*W EXP 08/01/203$2.8K0.0%
Portfolio Concentration
Top 3$768.53M96.6%
4–10$27.31M3.4%
11–25$2.8K0.0%
Top 3 weight
96.6%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 22.25M
Sole
Full voting authority
22.25M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole11
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings11
Rows:
SPDR S&P 500 ETF TR
SOLEShares1.15M
TypeSH
Market value$624.21M
78.43%
Sole
1.15M
Shared
0.00
None
0.00
ISHARES TR
SOLEShares2.43M
TypeSH
Market value$135.27M
17.00%
Sole
2.43M
Shared
0.00
None
0.00
FOGHORN THERAPEUTICS INC
SOLEShares1.57M
TypeSH
Market value$9.05M
1.14%
Sole
1.57M
Shared
0.00
None
0.00
ORIC PHARMACEUTICALS INC
SOLEShares989.41K
TypeSH
Market value$7.00M
0.88%
Sole
989.41K
Shared
0.00
None
0.00
ALECTOR INC
SOLEShares1.31M
TypeSH
Market value$5.94M
0.75%
Sole
1.31M
Shared
0.00
None
0.00
PMV PHARMACEUTICALS INC
SOLEShares2.63M
TypeSH
Market value$4.26M
0.53%
Sole
2.63M
Shared
0.00
None
0.00
23ANDME HOLDING CO
SOLEShares10.24M
TypeSH
Market value$4.01M
0.50%
Sole
10.24M
Shared
0.00
None
0.00
TENAYA THERAPEUTICS INC
SOLEShares1.02M
TypeSH
Market value$3.15M
0.40%
Sole
1.02M
Shared
0.00
None
0.00
RAPT THERAPEUTICS INC
SOLEShares657.90K
TypeSH
Market value$2.01M
0.25%
Sole
657.90K
Shared
0.00
None
0.00
SURROZEN INC
SOLEShares87.70K
TypeSH
Market value$960.3K
0.12%
Sole
87.70K
Shared
0.00
None
0.00
SURROZEN INC
SOLEShares170.83K
TypeSH
Market value$2.8K
<0.01%
Sole
170.83K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
SPDR S&P 500 ETF TRSOLE | TR UNIT | 1.15M | SH | $624.21M 78.43% | 1.15M | 0.00 | 0.00 |
ISHARES TRSOLE | MSCI INDIA ETF | 2.43M | SH | $135.27M 17.00% | 2.43M | 0.00 | 0.00 |
FOGHORN THERAPEUTICS INCSOLE | COM | 1.57M | SH | $9.05M 1.14% | 1.57M | 0.00 | 0.00 |
ORIC PHARMACEUTICALS INCSOLE | COM | 989.41K | SH | $7.00M 0.88% | 989.41K | 0.00 | 0.00 |
ALECTOR INCSOLE | COM | 1.31M | SH | $5.94M 0.75% | 1.31M | 0.00 | 0.00 |
PMV PHARMACEUTICALS INCSOLE | COM | 2.63M | SH | $4.26M 0.53% | 2.63M | 0.00 | 0.00 |
23ANDME HOLDING COSOLE | CLASS A COM | 10.24M | SH | $4.01M 0.50% | 10.24M | 0.00 | 0.00 |
TENAYA THERAPEUTICS INCSOLE | COM | 1.02M | SH | $3.15M 0.40% | 1.02M | 0.00 | 0.00 |
RAPT THERAPEUTICS INCSOLE | COM | 657.90K | SH | $2.01M 0.25% | 657.90K | 0.00 | 0.00 |
SURROZEN INCSOLE | COM NEW | 87.70K | SH | $960.3K 0.12% | 87.70K | 0.00 | 0.00 |
SURROZEN INCSOLE | *W EXP 08/01/203 | 170.83K | SH | $2.8K <0.01% | 170.83K | 0.00 | 0.00 |